Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2018 (2018), Article ID 7908950, 7 pages
https://doi.org/10.1155/2018/7908950
Research Article

Negative Regulation of PTEN by MicroRNA-221 and Its Association with Drug Resistance and Cellular Senescence in Lung Cancer Cells

Department of Thoracic Surgery, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

Correspondence should be addressed to Min Zheng; moc.621@mzrths

Received 29 October 2017; Accepted 1 January 2018; Published 30 January 2018

Academic Editor: Anne Hamburger

Copyright © 2018 Ning Wang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. Li and B. B. Yang, “Friend or foe: the role of microrna in chemotherapy resistance,” Acta Pharmacologica Sinica, vol. 34, no. 7, pp. 870–879, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. R. L. Siegel, K. D. Miller, and A. Jemal, “Cancer statistics, 2015,” CA: A Cancer Journal for Clinicians, vol. 65, no. 1, pp. 5–29, 2015. View at Publisher · View at Google Scholar · View at Scopus
  3. I. Berindan-Neagoe, P. D. C. Monroig, B. Pasculli, and G. A. Calin, “MicroRNAome genome: a treasure for cancer diagnosis and therapy,” CA: A Cancer Journal for Clinicians, vol. 64, no. 5, pp. 311–336, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. E. Lages, H. Ipas, A. Guttin, H. Nesr, F. Berger, and J.-P. Issartel, “MicroRNAs: molecular features and role in cancer,” Frontiers in Bioscience, vol. 17, no. 7, pp. 2508–2540, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. K. Lucas and A. S. Raikhel, “Insect MicroRNAs: Biogenesis, expression profiling and biological functions,” Insect Biochemistry and Molecular Biology, vol. 43, no. 1, pp. 24–38, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. F. H. Sarkar, Y. Li, Z. Wang, D. Kong, and S. Ali, “Implication of microRNAs in drug resistance for designing novel cancer therapy,” Drug Resistance Updates, vol. 13, no. 3, pp. 57–66, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. R. Hummel, C. Sie, D. I. Watson et al., “MicroRNA signatures in chemotherapy resistant esophageal cancer cell lines,” World Journal of Gastroenterology, vol. 20, no. 40, pp. 14904–14912, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. J. Zou, F. Yin, Q. Wang, W. Zhang, and L. Li, “Analysis of microarray-identified genes and microRNAs associated with drug resistance in ovarian cancer,” International Journal of Clinical and Experimental Pathology, vol. 8, pp. 6847–6858, 2015. View at Google Scholar
  9. R. García-Becerra, N. Santos, L. Díaz, and J. Camacho, “Mechanisms of resistance to endocrine therapy in breast cancer: focus on signaling pathways, miRNAs and genetically based resistance,” International Journal of Molecular Sciences, vol. 14, no. 1, pp. 108–145, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Rong, G. Chen, and Y. Dang, “Increased MiR-221 expression in hepatocellular carcinoma tissues and its role in enhancing cell growth and inhibiting apoptosis in vitro,” BMC Cancer, vol. 13, no. 1, article 21, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. Z. Zhang, B. Z. Cui, L. H. Wu, Q. L. Xu, Z. Wang, and B. Yang, “The inhibition effect of expressions of miR-221 and miR-222 on glioma and corresponding mechanism,” Bratislava Medical Journal, vol. 115, no. 11, pp. 685–691, 2014. View at Publisher · View at Google Scholar
  12. S. Galardi, N. Mercatelli, E. Giorda et al., “miR-221 and miR-222 expression affects the proliferation potential of human prostate carcinoma cell lines by targeting p27Kip1,” The Journal of Biological Chemistry, vol. 282, no. 32, pp. 23716–23724, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. Y. Wei, X. Lai, S. Yu et al., “Exosomal miR-221/222 enhances tamoxifen resistance in recipient ER-positive breast cancer cells,” Breast Cancer Research and Treatment, vol. 147, no. 2, pp. 423–431, 2014. View at Publisher · View at Google Scholar
  14. G. Viticchiè, A. M. Lena, A. Latina et al., “MiR-203 controls proliferation, migration and invasive potential of prostate cancer cell lines,” Cell Cycle, vol. 10, no. 7, pp. 1121–1131, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. T. Shatseva, D. Y. Lee, Z. Deng, and B. B. Yang, “MicroRNA miR-199a-3p regulates cell proliferation and survival by targeting caveolin-2,” Journal of Cell Science, vol. 124, no. 16, pp. 2826–2836, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Lerner, J. Lundgren, S. Akhoondi et al., “MiRNA-27a controls FBW7/hCDC4-dependent cyclin E degradation and cell cycle progression,” Cell Cycle, vol. 10, no. 13, pp. 2172–2183, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. L. Luo, G. Ye, L. Nadeem et al., “Microrna-378a-5p promotes trophoblast cell survival, migration and invasion by targeting Nodal,” Journal of Cell Science, vol. 125, no. 13, pp. 3124–3132, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. V. Siragam, Z. J. Rutnam, W. Yang et al., “Microrna mir-98 inhibits tumor angiogenesis and invasion by targeting activin receptor-like kinase-4 and matrix metalloproteinase-11,” Oncotarget , vol. 3, no. 11, pp. 1370–1385, 2012. View at Google Scholar · View at Scopus
  19. M. M. Zadeh, N. Motamed, N. Ranji, M. Majidi, and F. Falahi, “Silibinin-induced apoptosis and downregulation of microRNA-21 and MicroRNA-155 in MCF-7 human breast cancer cells,” Journal of Breast Cancer, vol. 19, no. 1, pp. 45–52, 2016. View at Publisher · View at Google Scholar · View at Scopus
  20. C. S. Lee, Y. J. Kim, E.-R. Jang, S. C. Myung, and W. Kim, “Akt inhibitor enhances apoptotic effect of carboplatin on human epithelial ovarian carcinoma cell lines,” European Journal of Pharmacology, vol. 632, no. 1-3, pp. 7–13, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. J.-P. Delord, S. Quideau, P. Rochaix et al., “Trastuzumab induced in vivo tissue remodelling associated in vitro with inhibition of the active forms of AKT and PTEN and RhoB induction in an ovarian carcinoma model,” British Journal of Cancer, vol. 103, no. 1, pp. 61–72, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. G. Sharma, S. Kar, S. Palit, and P. K. Das, “18β-glycyrrhetinic acid (concur) induces apoptosis through modulation of Akt/FOXO3a/Bim pathway in human breast cancer MCF-7 cells,” Journal of Cellular Physiology, vol. 227, no. 5, pp. 1923–1931, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. T.-S. Yang, X.-H. Yang, X.-D. Wang, Y.-L. Wang, B. Zhou, and Z.-S. Song, “MiR-214 regulate gastric cancer cell proliferation, migration and invasion by targeting PTEN,” Cancer Cell International, vol. 13, no. 1, article no. 68, 2013. View at Publisher · View at Google Scholar · View at Scopus